Key facts
- Notable investors include Gates Foundation, QUBIS, Queen's University Belfast.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Almac Group
- ·The full record, as it builds
Funding rounds
No funding rounds for Almac Group are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Almac Group
Operator of a research-driven drug discovery company intended for the development of novel and innovative therapeutics. The company offers diagnostic services, application programming interface services, pharmaceutical development, analytical services, clinical services and commercial services, delivering expertise across the drug development lifecycle, enabling clients with a tailored resolution.
- Sector
- Healthcare
- HQ
- Craigavon, United Kingdom
- Founded
- 2002
- Employees
- 7,500
- Website
- almacgroup.com/
- Ownership
- Privately Held (backing)
Almac Group doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Almac Group shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Almac Group in its N-PORT filings yet. We sweep new filings monthly.